Argo provides excellent coverage of this ocean volume during the 00s, and it shows less than half the amount of warming over these depths (Fig. 1) . In contrast, SODA compares well with observational results from WOA and Argo over the top 1000 m. This is expected, given SODA's ocean data assimilation scheme, which nudges the model toward the data without necessarily requiring energy to be conserved in the model domain. During the 00s, however, SODA does show significant cooling between 1000 and 2000 m, which seems contradictory to all observational estimates.
In terms of heat content integrated from the surface down, all reanalyses also show large deviations from observations ( fig. S7 ). Similar results have been found at regional scale (figs. S13 to S17). The observational rate of heat content increase over the 0-to 1500-m depth range did not change significantly between the 90s (2.0 × 10 21 J/year) and the 00s (3.4 × 10 21 J/year or 2.53 × 10 21 J/year, according to the observational average or Argo, respectively) (table S2). Thus, observational heat content estimates do not reveal any obvious hiatus. This suggests that since the early 90s, there has been a steady rate of net ocean heat uptake, and the amount of radiative imbalance at the top of the atmosphere remained practically unchanged between the 90s and the 00s. This contradicts one recent study (8) suggesting that the net ocean heat uptake was reduced during the 00s on the basis of changes in surface flux estimates.
Comparison of several of the most commonly used reanalyses with ocean observations raises concerns about their fidelity in simulating temperature changes or in quantitatively explaining the redistribution of heat associated with the recent surface temperature hiatus. Observational estimates provide a more accurate means of assessing oceanic temperature changes and show clear decadal signals that are robust across different analyses ( fig. S5 ) and clearly significant relative to observational errors. Our findings support the idea that the Indo-Pacific interaction in the upper-level water (0 to 300 m depth) regulated global surface temperature over the past two decades and can fully account for the recently observed hiatus. Furthermore, as previously shown for interannual fluctuations (11), the decade-long hiatus that began in 2003 is the result of a redistribution of heat within the ocean, rather than a change in the net warming rate.
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B
acterial toxins are the deadliest compounds on the planet. As little as a single molecule of a delivered toxin can compromise vital functions or even kill an affected host cell (1, 2) . This is achieved by amplification of a toxin enzymatic activity by signaling cascades (e.g., by cholera, pertussis, and anthrax toxins) or by enzymatic inhibition of vital host complexes present in relatively few copies (e.g., Shiga and diphtheria toxins acting on ribosomes). Such efficiency is crucial because (i) the amount of a toxin produced early after infection is limited by an initially small number of bacterial cells; (ii) the host is protected by commensal bacteria; and (iii) the host immune system efficiently neutralizes toxins by means of adaptive (antibodies) and innate (e.g., defensins) (3) humoral defense factors.
Owing to its importance in multiple cellular processes, actin is a common target for bacteriumand parasite-produced toxins. Upon delivery to the cytoplasm of host cells by type I (as part of MARTX toxin) (4) or type VI (within VgrG1 toxin) (5) secretion systems, the actin cross-linking domain toxin (ACD) catalyzes the covalent crosslinking of Lys 50 (K50) in subdomain 2 of one actin monomer with Glu 270 (E270) in subdomain 3 of another actin monomer by means of an amide bond, which results in the formation of actin oligomers (6, 7). The actin subunits in the oligomers are oriented similarly to short-pitch subunits in the filament, except that a major twist of subdomain 2, required to accommodate such orientation, disrupts the normal intersubunit interface and precludes polymerization (6) .
The currently accepted mechanism of ACD toxicity, by sequestering of bulk amounts of actin as nonfunctional oligomers, is compromised owing to the high concentration of actin (hundreds of micromolar) in a typical animal cell.
Extrapolation of in vitro determined rates of the ACD activity (7) to cellular conditions suggests that a single ACD molecule per cell (i.e.,~1 pM) would require >6 months to covalently cross-link half of all cytoplasmic actin.
In contrast to these estimations, the integrity of the intestinal cell monolayers was disrupted when only a small fraction of cellular actin (2 to 6%) was cross-linked by ACD (Fig. 1 , A to C, and fig. S1 ). To account for such dramatic effects, we hypothesized that the ACD-cross-linked actin oligomers are highly toxic because they can exert an abnormally high affinity to actin-regulatory proteins containing several actin-binding domains. To identify potential high-affinity partners of the actin oligomers, anthrax toxin delivery machinery was used to deliver ACD (8) into HeLa cells transfected with double-tagged (Twin-Strep-tag II and hemagglutinin) actin (SHA-actin) ( fig. S2 ) and used for a pull-down assay. Several formins (DIAPH1, DIAPH2, DAAM1, and INF2) preferentially bound to the ACD-cross-linked actin oligomers (Fig. 1D) . Treatment of epithelial monolayers with the formin inhibitor SMIFH2 affected the monolayer integrity similarly to ACD, whereas the Arp2/3 complex inhibitor CK-666 did not ( fig. S3 ).
Formins are a major family of actin assembly factors involved in numerous actin-dependent cellular processes. The major functional domains of formins, formin homology domains 1 (FH1) and 2 (FH2), cooperate in nucleation and elongation of actin filaments. A noncovalent FH2/FH2 homodimer nucleates and remains at the polymerizing barbed end to facilitate processive filament elongation while protecting the filament from capping (9) . Tandem poly(proline) (PP) stretches within the FH1 domains bind profilinactin complexes and accelerate elongation as much as 10-fold (10) (11) (12) . FH1 domains of all formins that preferentially bound to the oligomers (Fig. 1D ) contain 4 to 14 tandem PP stretches, which may contribute to strong profilin-mediated interaction with the oligomers.
To elucidate the mechanism of formin inhibition, we used constitutively active FH1-FH2 fragments of mDia1 and mDia2 (mouse orthologs of human DIAPH1 and DIAPH3, respectively) to monitor actin polymerization at the individual filament level by total internal reflection fluorescence microscopy (TIRFM) (Figs. 2 and 3 and  fig. S4 ). In the presence of human profilin-1 (PFN1), the oligomers caused very prominent reversible blocks of elongation of formin-controlled, but not formin-free, actin filaments (Fig. 2, A to F; fig. S4 , B and C; and movies S1 to S5). Formin-controlled filaments were identified by faster growth with a dimmer appearance (Fig. 2, A and E) (10) or by direct labeling of formin (Fig. 3A) .
In the presence of PFN1, the fraction of blocked mDia1 formin-associated filaments, as well as the inhibition of averaged growth rates, depended on the concentration of the added oligomers with an median inhibitory concentration (IC 50 ) of 1.2 ± 0.6 (SEM) nM (Fig. 2D) , in good agreement with the apparent equilibrium inhibition constant determined kinetically ( app K i = k off /k on = 2.5 nM) (Fig. 3,  C and D) . After stops (oligomer dissociation), the filaments continued to polymerize with the rates characteristic for formin-controlled filaments (Fig.  2B and fig. S4A ). In the absence of PFN1, the inhibition appeared to occur by a similar mechanism, S5, A and B, and fig. S6 ) assessed in the absence (E) and presence of PFN1 (F). (G) Apparent K i for inhibition of mDia1(14PP) by the oligomers in the presence of PFN1 was calculated by measuring IC 50 at two different concentrations of actin.
but the overall effect was weaker, and the average duration of the blockage events was substantially shorter (Fig. 2, C and D) . Although a profilin-mediated interaction of the oligomers with the PP stretches of FH1 was not absolutely required, it strongly amplified the efficiency of the inhibition at the elongation stage by contributing to multisite interaction with the oligomers. Thus, mDia1 constructs ( fig. S5A ) with either removed FH1 domains (FH2 only) or shortened from 14PP to 2PP stretches showed progressively lower response to inhibition by the oligomers in the presence of PFN1 (Fig. 3B) . Similarly, the app K i of oligomers for mDia2 (containing 2PP) was 7.5 times that for mDia1 and depended on PFN1 (Fig. 3, B to D) .
The inhibition of formin-mediated polymerization measured at the individual filament level correlated well with the inhibition observed in bulk pyrene assays (Fig. 4 and figs. S5 and S6 ). During spontaneous polymerization in the absence of PFN1, high concentrations (75 to 500 nM) of the oligomers mildly accelerated the polymerization, whereas mild inhibition was observed in the presence of profilin (Fig. 4, A and B) . This is likely because of a low level of incorporation of the oligomers into the filaments (6) in the absence, but not in the presence, of PFN1 ( fig. S5D) , which leads to filament severing similar to that observed for actin species with impaired intersubunit surfaces (13) .
In contrast, the oligomers potently inhibited actin polymerization directed by mDia1 in the presence and, to a lesser extent, the absence of PFN1 (Fig. 4, C to F, and fig. S6 ). Fitting the inhibition of actin polymerization at 50% of maximum to a binding isotherm equation resulted in an IC 50 for the mDia1(14PP) construct equal to 2.0 ± 0.2 nM and 4.8 ± 0.6 nM (SEM) in the presence and absence of PFN1 (Fig. 4, E and F) . The ACD-cross-linked actin dimers purified to homogeneity ( fig. S5B ) inhibited the mDia1-controlled polymerization less efficiently than the mixture of higher-order oligomers ( fig. S5, F to H) , which suggests that the inhibition is amplified by multivalent interactions of the oligomers with mDia1. Accordingly, shortening the FH1 domain progressively decreased the efficiency of inhibition, with the IC 50 values reaching~30 and~16 nM for the mDia1(FH2) constructs in the presence and absence of PFN1 (Fig. 4, E and F,  and fig. S6 ).
Kinetic modeling ( fig. S8 ) revealed that inhibition of both nucleation and elongation is required to accurately describe the effects of the oligomers on formin-controlled actin polymerization. Using experimentally determined parameter values for inhibition of elongation, we found good fits to the data (Fig. 4) by assuming that oligomers also inhibit nucleation by binding to free mDia1(14PP) formin with dissociation constants of 0.8 and 5 nM in the presence and absence of PFN1 ( fig. S8, D and E) . Inhibition of nucleation by the oligomers in the absence of PFN1 was also observed experimentally in filament seeding assays ( fig. S7 ) and TIRFM experiments ( fig. S4, D to G) . Similar experiments in the presence of PFN1 were less conclusive owing to the overall lower nucleation ability of formins under these conditions ( fig. S4, F and G, and fig.  S7 , G and H). To improve accuracy, modeling had to account for filament severing owing to incorporation of the oligomers in the absence of PFN1 (Fig. 4, A and C, and fig. S8, C and D) .
Bacterial toxins are well known to disorganize the actin cytoskeleton acting on Rho family guanosine triphosphatase-controlled signaling pathways (14) . Here, we found that toxins can not only exploit existing signaling pathways but also initiate a new toxicity cascade with de novo produced cross-linked actin species as "second messengers." Because of a unique combination of properties that is not present in Gor F-actin ( fig. S9A ), these new actin species bind with high affinity to formins and adversely affect both nucleation and elongation abilities of these proteins, which causes their potent inhibition in both profilin-dependent and independent manners ( fig. S9B ). Thus, ACD creates toxic derivatives of actin with a disruptive "gainof-function" mode of operation. We propose that the seemingly straightforward original assumption that ACD acts by the accumulation of bulk amounts of nonfunctional actin is inaccurate or at least incomplete. The toxin can be highly efficient at very low concentrations by acting on formins and, potentially, other actin regulatory proteins. This finding calls for the careful reevaluation of mechanisms used by other actinrelated toxins, both of protein and small-molecule natures. conducted pyrene actin and TIRFM experiments, analyzed data, and cowrote the manuscript; E.K. 
